Sheridan Admans, investment research manager at The Share Centre, gives his thoughts on what to expect from companies announcing results w/c 28 July 2014
Monday
National Grid (interim management statement)
We do not expect much in the way of excitement from the group. Investors will be anticipating the normal statement from a utility for trading to be in line with expectations in National Grid’s first update since its results in May. Investors should note any comments from management regarding its US operations.
We currently list National Grid as a BUY
Companies also reporting today include: Aberdeen Asset Management (Q3 results) – HOLD, and Reckitt Benckiser #(Q2 results) – HOLD
Tuesday
BP (Q2 results)
BP’s first quarter production numbers were marginally ahead of expectations and investors will be hoping for more of the same. The Ukraine/Russia situation lifted energy prices compared to the first quarter, so this should help with average realised oil prices. However, the group’s 20% ownership of Russian oil giant Rosneft could result in problems down the line if heftier sanctions are imposed on the country, following the recent shooting down of the Malaysian airline. Investors will therefore keep a close eye on any comments from management in regards to its Russian stake.
We currently list BP as a BUY
St James’s Place (interim management statement)
The group has been going from strength to strength and investors will be hoping for more of the same in regards to increasing funds under management, inflows of fresh money and dividend growth. Other areas to note will be any news of its proposed expansion into Asia and any early signs of benefits from changes made in this year’s budget to ISAs and pensions.
We currently list St James Place as a BUY
Companies also reporting today include: Hutchison China MediTech (Q2 results) – HOLD, Next (Q2 trading statement) – HOLD and GKN (Q2 results) – BUY
Wednesday
Barclays (Q2 results)
The sector has once again been under pressure this year, with Barclays’ share price suffering more than most. As usual the market will be concentrating on the performance of Barclays Capital. Investors could see further updates on its recently announced strategic review, alongside updates on regulatory issues and the resulting possible lawsuits. The market will also be focussing on the group’s outlook.
We currently list Barclays as a HOLD
Companies also reporting today include: 3i (interim management statement) – HOLD, ITV (Q2 results) – BUY, Antofagasta (Q2 results) – HOLD, Shire (Q2 results) – HOLD, Tullow Oil (Q2 results) – BUY, Vedanta Resources (Q1 results) – BUY, British American Tobacco (Q2 results) – HOLD and Compass (interim management statement) – HOLD
Thursday
Rolls Royce (Q2 results)
The update earlier this year disappointed the market after the company warned of no growth in sales for 2014. However, there is an expectation of a return to growth in 2015 and investors will look to see if the management still believe this. The slowdown in its defence businesses is believed to be one of the main contributors to the group’s decline. However, the majority of defence cutbacks should already have happened and therefore the future for the industry may begin to pick up. The key to Rolls Royce is the civil aerospace industry and this is where it is still performing very well. As well as sales numbers, investors will keep an eye out for the size of the order backlog and the mix between original equipment and after sales contracts.
We currently list Rolls Royce as a BUY
AstraZeneca (Q2 results)
GlaxoSmithKline disappointed the market with its update this week, next week it’s AstraZeneca’s turn. We will more than likely see generic competition continue to hurt the group’s revenue and profitability. However, with it rejecting Pfizer’s takeover approach earlier this year, investors will expect to see convincing comments that Astra can go it alone in developing their R&D assets. Updates on the progress of R&D projects will be sought after, as will the progress of its cost cutting programme.
We currently list AstraZeneca as a HOLD
Companies also reporting today include: Schroders (Q2 results) – HOLD, Weir Group (Q2 results) – HOLD, Centrica (Q2 results) – HOLD, Lloyds Banking (Q2 results) – HOLD, BAE Systems (Q2 results) – HOLD, Spirent Communications (Q2 results) – BUY, BG Group (Q2 results) – BUY, Royal Dutch Shell (Q2 results) – BUY, BT (Q1 results) – BUY and Diageo (Q4 results) – BUY
Friday
Smith & Nephew (Q2 results)
The company has been an exceptional performer of the last couple of years with excellent assets and growth prospects leaving it a target for potential acquisitions. There has been some interest from US firms but nothing has materialised just yet and investors will lookout for possible commentary from management on this matter.
We currently list Smith & Nephew as a HOLD
IMI (Q2 results)
IMI is a company that is currently having a strategic review as a result of a new CEO. Followers of the company will be nervous about the effects of currency on its profits and the potential for pressure on its margins. The group was forecasting an improvement in the second half so an update and confirmation of this trend on the outlook will be important to investors.
We currently list IMI as a HOLD
Companies also reporting today include: Royal Bank of Scotland (Q2 results) – SELL, Rexam (Q2 results) – HOLD, International Consolidated Airlines (Q2 results) – HOLD and William Hill (Q2 results) – BUY
Economic Diary
Announcements for the w/c 28 July
29 July, US consumer confidence, July
Conference Board; 30 July, US Gross Domestic Product (Advance), Q2 2014 – BEA; and US Employment Situation, July – BLS
In Q1 US GDP contracted at an annualised rate of 2.9 per cent. However, it is thought this was largely down to the exceptionally cold winter in the US and that Q2 will see a significant recovery. The latest PMIs are consistent with annualised growth of 3.0 per cent. Meanwhile, last month’s consumer confidence index from the Conference Board hit a six year high, and June saw 288,000 increase in non-farm payrolls.
1 August
Purchasing Managers’ Index for UK manufacturing – Markit/CIPS
Last month the manufacturing PMI rose to 57.0, which was the second highest reading for the index in 40 months. It is worth nothing, however, that recent data from the ONS on UK manufacturing in May was less positive than the corresponding PMI had suggested.
Other economic announcements include:
29 July
• Insolvency Statistics, Q2, 2014 – ONS
30 July
• FOMC Meeting – FED
31 July
• Help to Buy (equity loan) scheme and Help to Buy: NewBuy statistics, April 2013 to June 2014 – ONS
• Economic Review, August 2014 – ONS
• Flash estimate Euro area inflation, July – Eurostat
• EU unemployment, June – Eurostat
1 August
• PMIs covering manufacturing in the euro area – HSBC, US – ISM and Markit and China HSBC/Markit.
All information given including prices, yields and our opinion is correct at the time of publication. Our opinions on investments can change at any time and for our latest view please go to www.share.com. To understand how our Advice team arrive at their views please read our Investment Research Policy.
The post The forward look, w/c 28 July appeared first on The Share Centre Blog.